March 20, 2019
GEXVal participated in the 139th Annual Meeting of the Pharmaceutical Society of Japan
GEXVal participated in the 139th Annual Meeting of the Pharmaceutical Society of Japan (AMPSJ) held from March 20 to 23, 2019, at the International Conference Hall and International Exhibition Hall of Makuhari Messe and Hotel New Otani Makuhari. AMPSJ is always an important opportunity for participants from various fields related to the pharmaceutical industry to make presentations on pharmaceutical education and their state-of-the-art research, as well as to exchange information. As one of the invited participants, we were given the opportunity to make a presentation at the poster session of ISMS, the 5th International Symposium for Medical Science (ISMS-IPO2. Mao etal., New insights for drug repositioning: the integrative approach).
Dr. Juran Kato, who is the founder, President and CEO of GEXVal, made the following announcement:
“An enormous amount of real world data and big data accumulated in clinical trials has recently been actively employed for drug positioning research to create new values for existing medicines as well as to develop candidate compounds. At the meeting, we were given an extremely interesting opportunity to exchange opinions on future pharmaceutical development with pioneering researchers from around Japan. I would like to express my sincerest appreciation to AMPSJ and the secretariat for giving us such a precious opportunity.
＊139th Annual Meeting of the Pharmaceutical Society of Japan: http://nenkai.pharm.or.jp/139/web/
＊List of symposiums: http://nenkai.pharm.or.jp/139/pc/ssympo.asp?i=2248
＊Symposium held on 22 March (ISMS-IPO2): http://nenkai.pharm.or.jp/139/web/en/files/Symposia.pdf
For further information, please contact us: email@example.com